These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28921509)
1. BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. den Hartog G; van Osch TLJ; Vos M; Meijer B; Savelkoul HFJ; van Neerven RJJ; Brugman S Eur J Immunol; 2018 Feb; 48(2):283-292. PubMed ID: 28921509 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF. Abu-Rish EY; Amrani Y; Browning MJ Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580 [TBL] [Abstract][Full Text] [Related]
3. New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production? Liu Y; Liu H; Peng Y; Liu F Ren Fail; 2014 Jul; 36(6):970-3. PubMed ID: 24828398 [TBL] [Abstract][Full Text] [Related]
4. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Bombardieri M; Kam NW; Brentano F; Choi K; Filer A; Kyburz D; McInnes IB; Gay S; Buckley C; Pitzalis C Ann Rheum Dis; 2011 Oct; 70(10):1857-65. PubMed ID: 21798884 [TBL] [Abstract][Full Text] [Related]
5. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Tezuka H; Abe Y; Iwata M; Takeuchi H; Ishikawa H; Matsushita M; Shiohara T; Akira S; Ohteki T Nature; 2007 Aug; 448(7156):929-33. PubMed ID: 17713535 [TBL] [Abstract][Full Text] [Related]
6. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses. Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171 [TBL] [Abstract][Full Text] [Related]
7. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides. Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA Allergy; 2013; 68(5):593-603. PubMed ID: 23480796 [TBL] [Abstract][Full Text] [Related]
9. A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells. Hua C; Audo R; Yeremenko N; Baeten D; Hahne M; Combe B; Morel J; Daïen C J Autoimmun; 2016 Sep; 73():64-72. PubMed ID: 27372914 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production. Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556 [TBL] [Abstract][Full Text] [Related]
12. Comparison of human B cell activation by TLR7 and TLR9 agonists. Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679 [TBL] [Abstract][Full Text] [Related]
13. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Goto T; Bandoh N; Yoshizaki T; Nozawa H; Takahara M; Ueda S; Hayashi T; Harabuchi Y Clin Immunol; 2008 Mar; 126(3):260-9. PubMed ID: 18249037 [TBL] [Abstract][Full Text] [Related]
14. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. He B; Xu W; Santini PA; Polydorides AD; Chiu A; Estrella J; Shan M; Chadburn A; Villanacci V; Plebani A; Knowles DM; Rescigno M; Cerutti A Immunity; 2007 Jun; 26(6):812-26. PubMed ID: 17570691 [TBL] [Abstract][Full Text] [Related]
15. Increased serum concentration of BAFF/APRIL and IgA2 subclass in patients with mixed connective tissue disease complicated by interstitial lung disease. Kaneko T; Amano H; Kawano S; Minowa K; Ando S; Watanabe T; Nakano S; Suzuki J; Morimoto S; Tokano Y; Takasaki Y Mod Rheumatol; 2014 Mar; 24(2):310-5. PubMed ID: 24252051 [TBL] [Abstract][Full Text] [Related]
16. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. Fayette J; Dubois B; Vandenabeele S; Bridon JM; Vanbervliet B; Durand I; Banchereau J; Caux C; Brière F J Exp Med; 1997 Jun; 185(11):1909-18. PubMed ID: 9166420 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. Chu VT; Enghard P; Riemekasten G; Berek C J Immunol; 2007 Nov; 179(9):5947-57. PubMed ID: 17947668 [TBL] [Abstract][Full Text] [Related]
18. Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. Xu W; Santini PA; Matthews AJ; Chiu A; Plebani A; He B; Chen K; Cerutti A J Immunol; 2008 Jul; 181(1):276-87. PubMed ID: 18566393 [TBL] [Abstract][Full Text] [Related]
19. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells. Conley ME; Bartelt MS J Immunol; 1984 Nov; 133(5):2312-6. PubMed ID: 6332844 [TBL] [Abstract][Full Text] [Related]
20. Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses. Ruane D; Chorny A; Lee H; Faith J; Pandey G; Shan M; Simchoni N; Rahman A; Garg A; Weinstein EG; Oropallo M; Gaylord M; Ungaro R; Cunningham-Rundles C; Alexandropoulos K; Mucida D; Merad M; Cerutti A; Mehandru S J Exp Med; 2016 Jan; 213(1):53-73. PubMed ID: 26712806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]